Expensify amends Schedule TO for $25.0M tender offer
Expensify, Inc. filed Amendment No. 1 to its Schedule TO to amend its previously announced tender offer to repurchase up to $25,000,000 of Class A common stock at a price per share of not less than $0.98 and not more than $1.20.
Rhea-AI Filing Summary
Expensify, Inc. filed Amendment No. 1 to its Schedule TO to amend its previously announced tender offer to repurchase up to $25,000,000 of Class A common stock at a price per share of not less than $0.98 and not more than $1.20. The amendment updates the Offer to Purchase’s incorporation by reference to list Current Reports on Form 8-K filed on April 21, 2026, May 27, 2026 and May 29, 2026.
Positive
- None.
Negative
- None.
Insights
Amendment clarifies disclosure references for an ongoing $25.0M tender offer.
The amendment revises Item 11 "Incorporation by Reference" to include three Form 8-K filings dated April 21, 2026, May 27, 2026 and May 29, 2026. This is a disclosure update tied to an existing tender offer to repurchase up to $25,000,000 of Class A common stock at $0.98–$1.20 per share.
The change is procedural: it aligns the Offer to Purchase with recent Form 8-Ks. Cash‑flow treatment and timing mechanics of purchases remain as previously disclosed in the Offer to Purchase and Letter of Transmittal; subsequent filings will state any material changes to those mechanics.
Key Figures
Key Terms
Schedule TO regulatory
Offer to Purchase financial
Letter of Transmittal financial
Incorporation by Reference regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Expensify's amendment to the Schedule TO do?
How large is the tender offer announced by Expensify (EXFY)?
Does Amendment No. 1 change the tender offer price or amount?
Where can I find the documents added by the amendment?
AI-generated analysis. How Rhea-AI works. Not financial advice.